Exploring feature importance in machine learning for neuroimaging traits in Alzheimer's disease across a multiethnic cohort.
Authors
Affiliations (4)
Affiliations (4)
- Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA.
- Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, USA.
- Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA.
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, USA.
Abstract
BackgroundAlzheimer's disease (AD) affects 55 million people worldwide, projected to reach 139 million by 2050; yet, most machine learning (ML)-based AD classifiers have been developed in Non-Hispanic White (NHW) cohorts, limiting generalizability.ObjectiveAssess ethnic differences in AD prediction using classification performance and feature importance derived from multimodal neuroimaging biomarkers across African American (AA), Hispanic, and NHW participants.MethodsSupport vector machine classifiers were applied to multimodal neuroimaging data from a multi-ethnic cohort, incorporating structural magnetic resonance imaging measures, diffusion tensor imaging metrics, and positron emission tomography-based amyloid and tau measures. Models classified cognitively unimpaired (CU) versus cognitively impaired (CI) individuals and mild cognitive impairment (MCI) versus AD dementia, with and without adjustment for age, sex, and education.ResultsClassification performance varied by ethnicity and disease stage. NHW participants showed the strongest overall performance, particularly for CU versus CI, while Hispanic participants demonstrated high sensitivity and balanced performance for MCI versus AD. AA participants exhibited lower AUC and accuracy across tasks but maintained high negative predictive value. Demographic adjustment improved performance primarily for AA and NHW participants. Feature importance analyses revealed shared and population-specific patterns: tau positron emission tomography (PET) measures, especially posterior cingulate and lateral parietal standardized uptake value ratios, consistently ranked highest for CU versus CI across groups, whereas MCI versus AD classification diverged, with amyloid PET predominating in AA participants, tau PET in NHW participants, and mixed medial temporal atrophy and white matter signatures in Hispanics.ConclusionsShared early AD neuroimaging signatures exist across ethnic groups, but biomarker importance diverges at later disease stages, underscoring the need for ethnicity-aware ML models to improve prediction and equitable clinical translation.